---
document_datetime: 2023-09-21 21:18:25
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/opdualag-epar-all-authorised-presentations_en.pdf
document_name: opdualag-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.3502408
conversion_datetime: 2025-12-15 22:53:07.4918
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
## MA (EU) number (Invented) name Strength Pharmaceutical Form Administration Immediate Packaging Content (concentration) Pack size

EU/1/22/1679/001 Opdualag 240 mg / 80 mg Concentrate for solution for infusion Intravenous use vial (glass) 20 ml (12 mg/ml / 4 mg/ml) 1 vial